A Systems Pharmacology Analysis of Major Chemotherapy Combination Regimens Used in Gastric Cancer Treatment: Predicting Potential New Protein Targets and Drugs

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|11|7|849-869

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.11, Iss.7, 2011-09, pp. : 849-869

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current and Potential Chemotherapeutic Agents Used for Induction Chemotherapy in the Treatment of Breast Cancer

By  

Current Pharmaceutical Design, Vol. 6, Iss. 3, 2000-02 ,pp. : 327-343

Bentham Science Publishers

Access to resources Recommend Favorite

Protein Kinases as Targets for Antiparasitic Chemotherapy Drugs

By  

Current Drug Targets, Vol. 8, Iss. 3, 2007-01 ,pp. : 389-398

Bentham Science Publishers

Access to resources Recommend Favorite

Combination therapy a major advance in gastric cancer

By  

Inpharma, Vol. 1, Iss. 1241, 2000-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Fixed-Dose Combination Drugs for Tuberculosis: Application in Standardised Treatment Regimens

By Blomberg B.  

Drugs, Vol. 63, Iss. 6, 2003-01 ,pp. : 535-553

Adis International

Access to resources Recommend Favorite

Treatment of Borrmann Type IV Gastric Cancer with a Neoadjuvant Chemotherapy Combination of Docetaxel, Cisplatin and 5-Fluorouracil/Leucovorin

By Sun X-C   Lin J   Ju A-H  

The Journal of International Medical Research, Vol. 39, Iss. 6, 2011-11 ,pp. : 2096-2102

Field House Publishing

Access to resources Recommend Favorite